JEFFREY ROTHSTEIN, M.D.
Neurology at Wolfe St, Baltimore, MD
License number
Maryland D38291
Category
Neurology
Type
Neurology
Address
Address
600 N Wolfe St, Baltimore, MD 21287
Phone
(410) 955-9441
(410) 614-5972
(410) 614-5972
Personal information
See more information about JEFFREY ROTHSTEIN at radaris.comName
Address
Phone
41650 Ferber Ct, Leonardtown, MD 20650
533 Hilton Ave, Catonsville, MD 21228
9302 Fitzharding Ln, Owings Mills, MD 21117
12 Augustus Wally Ct APT 6, Reisterstown, MD 21136
12 Augustus Wally Ct, Reisterstown, MD 21136
Organization information
See more information about JEFFREY ROTHSTEIN at bizstanding.comJeffrey Rothstein MD
600 N Wolfe St, Baltimore, MD 21287
Industry:
Neurologist
Phone:
(410) 614-5972 (Phone)
Jeffrey David Rothstein
Jeffrey Rothstein
533 Hilton Ave, Baltimore, MD 21228
Status:
Inactive
Industry:
Nonclassifiable Establishments
Professional information
Professor Of Neurology And Neuroscience At Johns Hopkins School Of Medicine
Position:
Director, Brain Science Institute at Johns Hopkins School of Medicine
Location:
Baltimore, Maryland Area
Industry:
Research
Work:
Johns Hopkins School of Medicine
since 1986
-
Director, Brain Science Institute
Education:
University of Illinois at Chicago 1979 - 1985
MD, PhD, Medicine, Physiology, Biophysics University of Chicago 1977 - 1979
masters, Neuroscience
MD, PhD, Medicine, Physiology, Biophysics University of Chicago 1977 - 1979
masters, Neuroscience
Jeffrey David Rothstein, Baltimore MD
Specialties:
Neurology, Psychiatry, Cardiology
Work:
The Johns Hopkins Hospital
600 N Wolfe St, Baltimore, MD 21287 Johns Hopkins Outpatient Center
601 N Caroline St, Baltimore, MD 21287
600 N Wolfe St, Baltimore, MD 21287 Johns Hopkins Outpatient Center
601 N Caroline St, Baltimore, MD 21287
Education:
University of Illinois at Chicago (1985)
Dr. Jeffrey Rothstein, Baltimore MD - MD (Doctor of Medicine)
Specialties:
Neurology
Address:
JOHNS HOPKINS HOSPITAL
600 N Wolfe St, Baltimore 21287
(410) 955-3071 (Phone), (410) 955-1464 (Fax)
JOHNS HOPKINS HEALTHCARE - HOSP
601 N Caroline St, Baltimore 21287
(410) 995-6353 (Phone), (410) 614-2993 (Fax)
John Hopkins Hospital Neurology
855 N Wolfe St SUITE 248, Baltimore 21205
(410) 614-5972 (Phone)
600 N Wolfe St, Baltimore 21287
(410) 955-3071 (Phone), (410) 955-1464 (Fax)
JOHNS HOPKINS HEALTHCARE - HOSP
601 N Caroline St, Baltimore 21287
(410) 995-6353 (Phone), (410) 614-2993 (Fax)
John Hopkins Hospital Neurology
855 N Wolfe St SUITE 248, Baltimore 21205
(410) 614-5972 (Phone)
Certifications:
Neurology, 1990
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
JOHNS HOPKINS HOSPITAL
600 N Wolfe St, Baltimore 21287
JOHNS HOPKINS HEALTHCARE - HOSP
601 N Caroline St, Baltimore 21287
John Hopkins Hospital Neurology
855 N Wolfe St SUITE 248, Baltimore 21205
The Johns Hopkins Hospital
1800 Orleans St, Baltimore 21287
600 N Wolfe St, Baltimore 21287
JOHNS HOPKINS HEALTHCARE - HOSP
601 N Caroline St, Baltimore 21287
John Hopkins Hospital Neurology
855 N Wolfe St SUITE 248, Baltimore 21205
The Johns Hopkins Hospital
1800 Orleans St, Baltimore 21287
Education:
Medical School
Univ Of Il Coll Of Med
Graduated: 1985
Meml Hosp-University NC
The Johns Hopkins Hospital
Univ Of Il Coll Of Med
Graduated: 1985
Meml Hosp-University NC
The Johns Hopkins Hospital
Glutamate Transporter Associated Protein
US Patent:
7521536, Apr 21, 2009
Filed:
Aug 1, 2007
Appl. No.:
11/888900
Inventors:
Jeffrey D. Rothstein - Catonsville MD, US
Mandy Jackson - Baltimore MD, US
Glen Lin - Columbus OH, US
Robert Law - Owings Mills MD, US
Irina Orlov - Baltimore MD, US
Mandy Jackson - Baltimore MD, US
Glen Lin - Columbus OH, US
Robert Law - Owings Mills MD, US
Irina Orlov - Baltimore MD, US
Assignee:
The Johns Hopkins University School of Medicine - Baltimore MD
International Classification:
C07K 14/00, C07H 21/04
US Classification:
530350, 536 235
Abstract:
Glutamate Transporter Associated Proteins and nucleotide encoding Glutamate Transporter Associated Proteins are provided. Also provided is a method for identifying a compound that modulates a cellular response mediated by a Glutamate Transporter Associated Protein. A method is further provided for identifying a compound that inhibits an interaction between a Glutamate Transporter Associated Protein and a glutamate transporter protein. A method is provided for treating a disorder associated with glutamate transport.
Glutamate Transporter Associated Proteins And Methods Of Use Thereof
US Patent:
7252970, Aug 7, 2007
Filed:
Oct 25, 2004
Appl. No.:
10/972637
Inventors:
Jeffrey D. Rothstein - Catonsville MD, US
Mandy Jackson - Baltimore MD, US
Glen Lin - Columbus OH, US
Robert Law - Owings Mills MD, US
Irina Orlov - Baltimore MD, US
Mandy Jackson - Baltimore MD, US
Glen Lin - Columbus OH, US
Robert Law - Owings Mills MD, US
Irina Orlov - Baltimore MD, US
Assignee:
The Johns Hopkins University - Baltimore MD
International Classification:
C12N 15/00, C12N 15/63, C12N 15/85, C12N 15/86, C07H 21/04
US Classification:
435 691, 4353201, 435325, 536 231, 536 235, 530350
Abstract:
Glutamate Transporter Associated Proteins and nucleotide encoding Glutamate Transporter Associated Proteins are provided. Also provided is a method for identifying a compound that modulates a cellular response mediated by a Glutamate Transporter Associated Protein. A method is further provided for identifying a compound that inhibits an interaction between a Glutamate Transporter Associated Protein and a glutamate transporter protein. A method is provided for treating a disorder associated with glutamate transport.
Glutamate Transport Modulatory Compounds And Methods
US Patent:
2006012, Jun 8, 2006
Filed:
Feb 25, 2004
Appl. No.:
10/546860
Inventors:
Jeffrey Rothstein - Catonsville MD, US
International Classification:
C12Q 1/68, A61K 31/7048, A61K 31/385, C12N 15/87, A61K 31/28, A61K 31/17, A61K 31/137, A61K 31/14, A61K 31/56
US Classification:
435006000, 435455000, 514492000, 514440000, 514169000, 514358000, 514028000, 514588000, 514649000, 514642000
Abstract:
Described herein are methods of modulating excitatory amino acid transporter (EAAT) protein expression, methods of treating disease and disease symptoms, methods of identifying compounds that modulate EAAT protein expression, and compounds useful for modulating EAAT protein expression and treating disease and disease symptoms.
Aberrant Glutamate Transporters And Methods Of Use
US Patent:
7060457, Jun 13, 2006
Filed:
Mar 18, 1998
Appl. No.:
09/040736
Inventors:
Jeffrey D. Rothstein - Baltimore MD, US
Lynn A. Bristol - Baltimore MD, US
Lynn A. Bristol - Baltimore MD, US
Assignee:
Johns Hopkins University - Baltimore MD
International Classification:
C12N 15/00, C12N 1/20, C12N 15/63, C07H 21/04
US Classification:
435 691, 4353201, 4352521, 536 231
Abstract:
In one aspect, the present invention features methods for detecting at least one neurological disorder in a patient, the method comprising obtaining a biological sample from the patient; and detecting at least one aberrant human glutamate transporter 2 (EAAT 2) mRNA in the sample as being indicative of the neurological disorder in the patient. In a particular aspect, the invention is useful for detecting amyotrophic lateral sclerosis (ALS) in the patient.
Methods For Detecting Neurological Disorders
US Patent:
2006004, Feb 23, 2006
Filed:
Oct 28, 2005
Appl. No.:
11/261228
Inventors:
Jeffrey Rothstein - Baltimore MD, US
Lynn Bristol - Baltimore MD, US
Lynn Bristol - Baltimore MD, US
Assignee:
Johns Hopkins University - Baltimore MD
International Classification:
C12Q 1/68
US Classification:
435006000
Abstract:
In one aspect, the present invention features methods for detecting at least one neurological disorder in a patient, the method comprising obtaining a biological sample from the patient; and detecting at least one aberrant human glutamate transporter 2 (EAAT 2) mRNA in the sample as being indicative of the neurological disorder in the patient. In a particular aspect, the invention is useful for detecting amyotrophic lateral sclerosis (ALS) in the patient.
Target For Therapy Of Cognitive Impairment
US Patent:
2008017, Jul 24, 2008
Filed:
Mar 3, 2008
Appl. No.:
12/074550
Inventors:
Michela Gallagher - Baltimore MD, US
Pauline Kay Lund - Carrboro NC, US
Jeffrey D. Rothstein - Catonsville MD, US
Pauline Kay Lund - Carrboro NC, US
Jeffrey D. Rothstein - Catonsville MD, US
International Classification:
C07D 501/16, C07D 505/00
US Classification:
540215, 540301
Abstract:
The invention relates to methods of identifying genes involved in cognitive impairment and compositions for treating cognitive impairment.
Neuroprotection With Beta-Lactam Compounds
US Patent:
2007023, Oct 11, 2007
Filed:
Oct 21, 2004
Appl. No.:
10/576670
Inventors:
Jeffrey Rothstein - Catonsville MD, US
Dorothy Chung - Potomac MD, US
Dorothy Chung - Potomac MD, US
Assignee:
Johns Hopkins University - Baltimore MD
International Classification:
A61K 31/545, A61K 31/546, G01N 33/53, G01N 33/561
US Classification:
514206000, 435007100, 436516000, 514200000
Abstract:
Described herein are methods of treating or preventing neurological disease and disease symptoms using beta-lactam compounds, and compounds useful for treating disease and disease symptoms.